These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 12704533

  • 1. Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trial.
    Zhou Y, Rosenthal D, Dutz J, Ho V.
    J Cutan Med Surg; 2003; 7(3):193-7. PubMed ID: 12704533
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.
    Geilen CC, Arnold M, Orfanos CE.
    Br J Dermatol; 2001 Mar; 144(3):583-6. PubMed ID: 11260019
    [Abstract] [Full Text] [Related]

  • 3. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.
    Daudén E, Sánchez-Peinado C, Ruiz-Genao D, García-F-Villalta M, Onate MJ, García-Díez A.
    Br J Dermatol; 2004 Jan; 150(1):132-5. PubMed ID: 14746627
    [Abstract] [Full Text] [Related]

  • 4. A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.
    Beissert S, Pauser S, Sticherling M, Frieling U, Loske KD, Frosch PJ, Haase I, Luger TA.
    Dermatology; 2009 Jan; 219(2):126-32. PubMed ID: 19546522
    [Abstract] [Full Text] [Related]

  • 5. Enteric-coated mycophenolate sodium in psoriasis vulgaris: an open pilot study.
    Fallah Arani S, Waalboer Spuij R, Nijsten T, Neumann HA, Thio B.
    J Dermatolog Treat; 2014 Feb; 25(1):46-9. PubMed ID: 22998609
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
    Akhyani M, Chams-Davatchi C, Hemami MR, Fateh S.
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
    [Abstract] [Full Text] [Related]

  • 7. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.
    Pedraz J, Daudén E, Delgado-Jiménez Y, García-Río I, García-Díez A.
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):702-6. PubMed ID: 16836499
    [Abstract] [Full Text] [Related]

  • 8. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.
    Grundmann-Kollmann M, Mooser G, Schraeder P, Zollner T, Kaskel P, Ochsendorf F, Boehncke WH, Kerscher M, Kaufmann R, Peter RU.
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):835-7. PubMed ID: 10775866
    [Abstract] [Full Text] [Related]

  • 9. Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis.
    Davison SC, Morris-Jones R, Powles AV, Fry L.
    Br J Dermatol; 2000 Aug; 143(2):405-7. PubMed ID: 10951153
    [Abstract] [Full Text] [Related]

  • 10. Psoriasis vulgaris treated successfully with mycophenolate mofetil.
    Haufs MG, Beissert S, Grabbe S, Schütte B, Luger TA.
    Br J Dermatol; 1998 Jan; 138(1):179-81. PubMed ID: 9536244
    [Abstract] [Full Text] [Related]

  • 11. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

  • 12. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.
    Lau CH, Comer M, Lightman S.
    Clin Exp Ophthalmol; 2003 Dec 15; 31(6):487-91. PubMed ID: 14641155
    [Abstract] [Full Text] [Related]

  • 13. Conversion to enteric-coated mycophenolate sodium from various doses of mycophenolate mofetil: results of a prospective international multicenter trial in maintenance renal transplant patients receiving cyclosporine.
    Nashan B, Suwelack B, Ivens K, Arns W, Lhotta K, Bourbigot B, Budde K, Fischer W, Pietruck F, ERL2405-DE02 Study Group.
    Transplant Proc; 2006 Nov 15; 38(9):2856-9. PubMed ID: 17112848
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil and skin diseases.
    Hartmann M, Enk A.
    Lupus; 2005 Nov 15; 14 Suppl 1():s58-63. PubMed ID: 15803935
    [Abstract] [Full Text] [Related]

  • 15. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC, Orfanos-Boeckel H, Offermann G, Orfanos CE.
    Hautarzt; 2000 Feb 15; 51(2):63-9. PubMed ID: 10743574
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic drug monitoring of mycophenolic acid in patients with psoriasis.
    Daudén E, Pedraz J, Alvarez-Ruiz S, García-Río I, Sánchez-Peinado C, Oñate MJ, García-Diez A.
    Eur J Dermatol; 2010 Feb 15; 20(3):321-2. PubMed ID: 20146966
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR.
    Ophthalmology; 2003 Sep 15; 110(9):1750-5. PubMed ID: 13129873
    [Abstract] [Full Text] [Related]

  • 18. Coexistent psoriasis and bullous pemphigoid responding to mycophenolate mofetil monotherapy.
    Rallis E, Anyfantakis V.
    Skinmed; 2008 Sep 15; 7(2):101-2. PubMed ID: 18327004
    [Abstract] [Full Text] [Related]

  • 19. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.
    Kitchin JE, Pomeranz MK, Pak G, Washenik K, Shupack JL.
    J Am Acad Dermatol; 1997 Sep 15; 37(3 Pt 1):445-9. PubMed ID: 9308561
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial.
    Dussol B, Morange S, Burtey S, Indreies M, Cassuto E, Mourad G, Villar E, Pouteil-Noble C, Karaaslan H, Sichez H, Lasseur C, Delmas Y, Nogier MB, Fathallah M, Loundou A, Mayor V, Berland Y.
    Am J Kidney Dis; 2008 Oct 15; 52(4):699-705. PubMed ID: 18585835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.